The nefarious impact of hidden inflammation on your organ systems
Inflammation is the body’s natural response to infection, injury, or tissue damage. However, chronic inflammation can have severe consequences for the body, leading to the development of numerous health problems. Hidden inflammation refers to a low-grade, persistent inflammation that often goes unnoticed, but can have serious effects on the body. This article will explore the impact of hidden inflammation on various organ systems in the body, with references to scientific studies.
Chronic inflammation has been shown to contribute to the development of cardiovascular diseases, such as atherosclerosis, coronary artery disease, and stroke. Hidden inflammation is associated with elevated levels of C-reactive protein (CRP), which is a marker of systemic inflammation. Elevated levels of CRP have been linked to an increased risk of heart attack and stroke. Studies have also suggested that hidden inflammation can lead to endothelial dysfunction, which can contribute to the development of atherosclerosis.
Inflammation plays a crucial role in the development of respiratory diseases, such as asthma, chronic obstructive pulmonary disease (COPD), and lung cancer. Hidden inflammation has been linked to an increased risk of developing these conditions. A study conducted by Petersen et al. found that systemic inflammation was associated with a decline in lung function in middle-aged adults, suggesting that hidden inflammation may contribute to the development of COPD.
Hidden inflammation can also affect the digestive system. Chronic inflammation of the gastrointestinal tract has been linked to the development of inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis. In addition, hidden inflammation has been linked to an increased risk of developing colorectal cancer. A study by Pai et al. found that elevated levels of CRP were associated with an increased risk of developing colorectal cancer.
Chronic inflammation has been linked to the development of several neurological disorders, such as Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis (9). Hidden inflammation has been shown to contribute to the development of these conditions. For example, a study by Holmes et al. found that elevated levels of CRP were associated with an increased risk of developing Alzheimer’s disease.
Hidden inflammation can have serious consequences for various organ systems in the body. It is associated with an increased risk of developing cardiovascular, respiratory, digestive, and neurological diseases. Understanding the impact of hidden inflammation on the body is crucial for the development of preventive and therapeutic strategies for these conditions.
If you or anyone you know is suffering from body pain, inflammatory disorders, etc. please contact Specialized Therapy Associates at 201-488-6678 or The Functional Medicine Center for Personalized Care, LLC (www.FxMedCenters.com) at 201-880-8247 for our Integrative Mind-Body Health services which can greatly help you with holistic mind-body healing.
Barnes PJ. mechanisms in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2016;138(1):16-27.
Bennett JM, Reeves G, Billman GE, Sturmberg JP. Nature’s Way to Efficiently Respond to All Types of Challenges: Implications for Understanding and Managing “the Epidemic” of Chronic Diseases. Front Med (Lausanne). 2018 Nov 27;5:316. doi: 10.3389/fmed.2018.00316. PMID: 30538987; PMCID: PMC6277637.
Coussens LM, Werb Z. I. and cancer. Nature. 2002 Dec 19-26;420(6917):860-7. doi: 10.1038/nature01322. PMID: 12490959; PMCID: PMC2803035.
Chen L, Deng H, Cui H, Fang J, Zuo Z, Deng J, Li Y, Wang X, Zhao L. Inflammatory responses and i-associated diseases in organs. Oncotarget. 2017 Dec 14;9(6):7204-7218. doi: 10.18632/oncotarget.23208. PMID: 29467962; PMCID: PMC5805548.
Mann DL. Inflammatory mediators and the failing heart: past, present, and the foreseeable future. Circ Res. 2002;91(11):988-98.
Ridker PM, et al. C-reactive protein and other markers of I. in the prediction of cardiovascular disease in women. N Engl J Med. 2000;342(12):836-43.
Leave a reply
Leave a reply